Literature DB >> 17764059

The spectrum of scleroderma lung disease.

Kristin B Highland1, Margaret C Garin, Kevin K Brown.   

Abstract

Pulmonary disease is the most common cause of death in patients with systemic sclerosis. This article discusses the variety of ways the lung is affected in systemic sclerosis. These include pulmonary hypertension, interstitial lung disease and other restrictive disorders, obstructive disease, pleural disease, lung cancer, and aspiration. For each manifestation we outline the current knowledge of etiology, risk factors, diagnosis, treatment, and prognosis. We also discuss the current state of lung transplantation in this population.

Entities:  

Mesh:

Year:  2007        PMID: 17764059     DOI: 10.1055/s-2007-985613

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  8 in total

1.  Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis.

Authors:  Jingliang Yan; Andrew T Strong; Gautam Sharma; Scott Gabbard; Prashanti Thota; John Rodriguez; Matthew Kroh
Journal:  Surg Endosc       Date:  2018-02-12       Impact factor: 4.584

Review 2.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

3.  Scleroderma lung disease.

Authors:  Jérôme Le Pavec; David Launay; Stephen C Mathai; Paul M Hassoun; Marc Humbert
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

4.  Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis.

Authors:  Kristine Phillips; Cathryn Byrne-Dugan; Eric Batterson; James R Seibold
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

Review 5.  Treatment for systemic sclerosis-associated interstitial lung disease.

Authors:  David Roofeh; Alain Lescoat; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2021-05-01       Impact factor: 4.941

6.  Interstitial lung disease in Indonesian adult with systemic sclerotic: A rare case.

Authors:  Adhitri Anggoro; Helmia Hasan
Journal:  Ann Med Surg (Lond)       Date:  2022-02-11

7.  Lung cancer and interstitial lung diseases: a systematic review.

Authors:  Kostas Archontogeorgis; Paschalis Steiropoulos; Argyris Tzouvelekis; Evangelia Nena; Demosthenes Bouros
Journal:  Pulm Med       Date:  2012-07-29

8.  A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice.

Authors:  Xue Yang; Chi Liu; Masayuki Fujino; Ji Yang; Xiao-Kang Li; Hejian Zou
Journal:  FEBS Open Bio       Date:  2017-08-16       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.